CAPI Oncology & Hematology Summit
April 27, 2024
On The Future of Oncology & Hematology
Caribe Royale Resort - Convention Center - Orlando, Florida
Thank you Attendees, Speakers and Exhibitors! The annual CAPI Oncology & Hematology Summit brought together 30 top oncologists and hematologists from Central Florida to join industry innovators for an intensive learning experience. A strategically crafted invitation-only attendee list blended with a thoughtfully curated program - delivered an inspiring experience to advance attendees in the field of oncology.
aTTENDEES
A total of 30 top Oncologists and Hematologists are selected by a committee to attend. As invited guests conference fees are hosted by CAPI. No CME credit offered at this conference. To reply to an invitation extended by the committee register below (non transferrable invitation only).
sponsors
The CAPI Oncology Summit provides a one-day intensive learning canvas, ideal to showcase your unique expertise in the field of oncology and hematology healthcare. Engagement opportunities include designing a speaker session, activating your brand in the exhibitor showcase, and other customized networking experiences.
speakers
The CAPI Oncology Summit is honored to welcome a list of esteemed experts. As a speaker please use the code provided in your agreement to access to the speaker portal to download your speaker kit, upload presentation materials, and access key information about your engagement.
.png)
.png)
The Program
CAPI Oncology Summit
April 27, 2024
Caribe Royale Resort - Orlando
Sessions Located In: Curacao 1 & 2
Exhibition and Meals Located In: Curacao 5, 6 & 7
8am - Registration and Breakfast
9am - Welcome from CAPI Leadership Team
9:15pm - 9:45pm Sponsored by Orlando Health
Metastatic Melanoma: Review of the New FDA Approval of Lifileucel
Speaker: Sajeve Thomas, MD - Hematology & Oncology - Orlando Health
9:45am - 10:15am Sponsored by Genentech
Genentech Lymphoma Portfolio Updates - Columvi and Polivy
Speaker: Jessica Hurley, Pharm.D. - Senior Medical Science Liaison, Malignant Hematology - Florida and Puerto Rico
10:15am - 10:45am Sponsored by Rigel
REZLIDHIA Induces Durable Complete Remissions In Adult Patients With Relapsed/Refractory mIDH1 AML
Speaker: Yasser A. Khaled, MD, is the medical director of the Orlando Health Cancer Institute Bone Marrow Transplant and Cellular Therapy program.
10:45am - 11:30am Power Break/Exhibit Floor/Networking
11:30am - 12:00pm Sponsored by Natera
Molecular Residual Disease - Utilization of Signatera, a personalized ctDNA Test
Speaker: Sajeve Thomas, MD - Hematology & Oncology - Orlando Health
12:00pm - 12:30pm Sponsored by Daiichi-Sankyo
HER2 Expression Informs Eligibility for Enhertu in 2L HER2+ or HER2-low mBC
Speaker: Nikita Shah, MD - Orlando Health Cancer Institute
12:30pm - 1:00pm Sponsored by CSL Behring
Revolutionizing Hemophilia B Treatment: The Promise of Hemgenix (Etranacogene Dezaparvovec-drlb), the First FDA-Approved Gene Therapy
Speaker: Daniel Van Dorn, PharmD. - CSL Behring Medical Affairs-Coagulation
1:00pm - 2:00 Lunch Exhibit Floor/Networking
2:00pm - 2:30pm Sponsored by BeiGene
Discussion of Brukinsa for Adult Patients with Chronic lymphocytic leukemia (CLL) and Small lymphocytic lymphoma (SLL)
Speaker: Javier Pinilla MD, PhD - Senior Member and Head of Lymphoma Section- Dept Of Malignant Hematology - Moffitt Cancer Center - Tampa, Florida
2:30pm - 3:00pm Sponsored by Sobi
Exploring phenotypes in myelofibrosis (MF) and the role of VONJO® (pacritinib)
Speaker: Raji Shameem, MD - Orlando Health.
3:00pm - 4:00pm - Integration and Networking
4:00pm - Event Ends
Conference Leadership
.png)
.png)
